Humana to Waive Medical Costs Related to Coronavirus Treatment

Costs waived whether care is virtual, in a doctor’s office or hospital setting

LOUISVILLE, Ky. – March 30, 2020 – Humana (NYSE: HUM), a national health care company, has announced it is waiving consumer costs for treatment related to COVID-19-covered services. The company previously announced that it would cover out-of-pocket costs related to coronavirus testing. Now, costs related to subsequent treatment for COVID-19—including inpatient hospital admissions— will be waived for enrollees of Medicare Advantage plans, fully insured commercial members, Medicare Supplement and Medicaid.

Comments are closed.